Gene · 10800
Papers1,455
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,455
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms. | Clin Rev Allergy Immunol | 2025 | 40879847 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis. | Hepatol Commun | 2025 | 40879475 | PubTator, text mining | PubMed |
| Dysregulation of the leukotriene pathway in Parkinson's disease: The potential role of montelukast. | Cytokine | 2025 | 40812140 | PubTator, text mining | PubMed |
| Effect of Aspirin Challenge on Innate Lymphoid Cells in Asthma Patients With Aspirin Hypersensitivity. | Eur J Immunol | 2025 | 40755081 | PubTator, text mining | PubMed |
| Early-life exposure to polypropylene nanoplastics induces neurodevelopmental toxicity in mice and human iPSC-derived cerebral organoids. | J Nanobiotechnology | 2025 | 40597354 | PubTator, text mining | PubMed |
| Montelukast: A Scientific and Legal Review. | J Assoc Physicians India | 2025 | 40553531 | PubTator, text mining | PubMed |
| Characterization of a water soluble quininib prodrug that blocks metabolic activity and proliferation of multiple cancer cell lines. | Eur J Med Chem | 2025 | 40472485 | PubTator, text mining | PubMed |
| Integrated transcriptomic analysis of COVID-19 stages and recovery: insights into key gene signatures, immune features, and diagnostic biomarkers through machine learning. | Front Genet | 2025 | 40444276 | PubTator, text mining | PubMed |
| Unlocking GPCR-ligand interactions: Measuring binding affinities with thermal shift assay. | Protein Sci | 2025 | 40247825 | PubTator, text mining | PubMed |
| Structural basis of the cysteinyl leukotriene receptor type 2 activation by LTD4. | Proc Natl Acad Sci U S A | 2025 | 40193607 | PubTator, text mining | PubMed |
| Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [11C]PBR28 PET. | Mov Disord | 2025 | 39912596 | PubTator, text mining | PubMed |
| Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic activity in aged mice. | Aging (Albany NY) | 2025 | 39891615 | PubTator, text mining | PubMed |
| Antiviral and Immunomodulatory Effects of Zafirlukast Against Flaviviruses via Inhibition of the TNF Signaling Pathway. | J Med Virol | 2025 | 39737528 | PubTator, text mining | PubMed |
| vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual Screening. | Int J Mol Sci | 2024 | 39596415 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part IV. | Rom J Morphol Embryol | 2024 | 39529332 | PubTator, text mining | PubMed |
| Cysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy. | Invest Ophthalmol Vis Sci | 2024 | 39504050 | PubTator, text mining | PubMed |
| CYSLTR1 antagonism displays potent anti-tumor effects in uveal melanoma. | Exp Eye Res | 2024 | 39389443 | PubTator, text mining | PubMed |
| CysLT receptor-mediated NOX2 activation is required for IL-8 production in HMC-1 cells induced by Trichomonas vaginalis-derived secretory products. | Parasites Hosts Dis | 2024 | 39218626 | PubTator, text mining | PubMed |
| Prediction of the binding interactions between rosmarinic acid and cysteinyl leukotriene receptor type 1 by molecular docking and immobilized receptor chromatography. | RSC Adv | 2024 | 39091377 | PubTator, text mining | PubMed |
| Potential of Anti-Leukotriene Drugs as New Therapeutic Agents for Inhibiting Cholangiocarcinoma Progression. | Molecules | 2024 | 39064957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10800/papers?page=2